How Donated Pancreases and Immunology Research Are Opening New Paths in Type 1 Diabetes

Researchers are studying pancreatic tissue from people with Type 1 diabetes to understand what happens inside the organ during the disease. These insights are fueling new approaches to preserve insulin production and potentially reverse the condition.

Community video — lay discussion, not peer-reviewed research

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cureresearchclinical trial

Key takeaways

Scientists have limited ability to study living pancreases in people with Type 1 diabetes, making donated tissue samples invaluable for research
Pancreatic tissue donation programs like InPouch are helping researchers learn what actually happens in the pancreas during Type 1 diabetes
Current research is focused on two main goals: preserving remaining insulin production and developing therapies that could reverse Type 1 diabetes
Direct-funding models like the Diabetes Research Connection let people with Type 1 diabetes choose which research projects to support

The Challenge: What We Cannot See

One of the biggest obstacles in Type 1 diabetes research is simple but profound: scientists cannot easily study what happens inside the pancreas of a living person with the disease. Unlike blood tests or imaging scans, there is no routine way to observe the pancreatic tissue where insulin-producing beta cells live and die.

This knowledge gap has frustrated researchers for years. To move forward in developing new treatments, they need to understand the actual biological processes unfolding in the pancreas.

Pancreatic Tissue Donation: A New Window

A research collaboration called InPouch is changing this. The program collects pancreatic tissue samples from people with Type 1 diabetes who choose to donate their organs after death. These donated samples allow researchers to examine what is happening at the cellular level during the disease.

According to researchers involved in this work, these tissue samples have already yielded significant insights. By studying donated pancreases, scientists are learning details about the disease process that were previously invisible—knowledge that is now informing the next generation of treatment approaches.

Two Research Directions: Preserve and Reverse

Cure-focused research teams are pursuing two main goals. The first is to preserve insulin production in people with newly diagnosed Type 1 diabetes—protecting the beta cells that remain before they are lost. The second is to develop therapies that could reverse the disease by restoring insulin production.

These efforts draw heavily on immunology research, which explores how the immune system attacks beta cells and how that process might be stopped or reversed.

Community-Driven Research Funding

Beyond the laboratory, new funding models are emerging. Organizations like the Diabetes Research Connection are allowing people with Type 1 diabetes, their families, and supporters to directly fund specific research projects that interest them. This approach shifts some funding decisions away from traditional grant committees and toward the people most affected by the disease.

Evidence label

Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.